Genetic Inactivation of ZCCHC6 Suppresses Interleukin-6 Expression and Reduces the Severity of Experimental Osteoarthritis in Mice.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
04 2019
Historique:
received: 11 04 2018
accepted: 03 10 2018
pubmed: 12 10 2018
medline: 28 12 2019
entrez: 11 10 2018
Statut: ppublish

Résumé

Cytokine expression is tightly regulated posttranscriptionally, but high levels of interleukin-6 (IL-6) in patients with osteoarthritis (OA) indicate that regulatory mechanisms are disrupted in this disorder. The enzyme ZCCHC6 (zinc-finger CCHC domain-containing protein 6; TUT-7) has been implicated in posttranscriptional regulation of inflammatory cytokine expression, but its role in OA pathogenesis is unknown. The present study was undertaken to investigate whether ZCCHC6 directs the expression of IL-6 and influences OA pathogenesis in vivo. Human and mouse chondrocytes were stimulated with recombinant IL-1β. Expression of ZCCHC6 in human chondrocytes was knocked down using small interfering RNAs. IL-6 transcript stability was determined by actinomycin D chase, and 3'-uridylation of microRNAs was determined by deep sequencing. Zcchc6 ZCCHC6 was markedly up-regulated in damaged cartilage from human OA patients and from wild-type mice with surgically induced OA. Overexpression of ZCCHC6 induced the expression of IL-6, and its knockdown reduced IL-6 transcript stability and IL-1β-induced IL-6 expression in chondrocytes. Reintroduction of Zcchc6 in Zcchc6 These findings indicate that ZCCHC6 enhances IL-6 expression in chondrocytes through transcript stabilization and by uridylating miR-26b, which abrogates repression of IL-6. Inhibition of IL-6 expression and significantly reduced OA severity in Zcchc6

Identifiants

pubmed: 30302948
doi: 10.1002/art.40751
pmc: PMC6438766
mid: NIHMS992223
doi:

Substances chimiques

Interleukin-6 0
RNA, Small Interfering 0
Nucleotidyltransferases EC 2.7.7.-
RNA Nucleotidyltransferases EC 2.7.7.-
terminal uridylyl transferase 7, mouse EC 2.7.7.-
TUT7 protein, human EC 2.7.7.52

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

583-593

Subventions

Organisme : NCCIH NIH HHS
ID : R01 AT007373
Pays : United States
Organisme : Northeast Ohio Medical University
Pays : International
Organisme : NCCIH NIH HHS
ID : R01 AT003627
Pays : United States
Organisme : NCCIH NIH HHS
ID : R01 AT005520
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR067056
Pays : United States

Informations de copyright

© 2018, American College of Rheumatology.

Références

Crit Rev Biochem Mol Biol. 2004 Jul-Aug;39(4):197-216
pubmed: 15596551
Curr Opin Struct Biol. 2005 Feb;15(1):94-8
pubmed: 15718139
Arthritis Res Ther. 2014 Sep 26;16(5):441
pubmed: 25256035
Mol Cell Biol. 2007 May;27(10):3612-24
pubmed: 17353264
Osteoarthritis Cartilage. 2018 Aug;26(8):1087-1097
pubmed: 28801211
Bioinformatics. 2015 Oct 15;31(20):3365-7
pubmed: 26093149
Nat Struct Mol Biol. 2009 Jun;16(6):616-23
pubmed: 19430462
EMBO J. 2015 Jul 2;34(13):1801-15
pubmed: 25979828
Cytokine. 2017 Jan;89:21-26
pubmed: 26586165
J Biol Chem. 2008 Feb 22;283(8):4850-65
pubmed: 18065760
RNA. 2012 Oct;18(10):1875-85
pubmed: 22898984
Osteoarthritis Cartilage. 2010 Oct;18 Suppl 3:S17-23
pubmed: 20864019
Nucleic Acids Res. 2014 Oct;42(18):11777-91
pubmed: 25223788
Biomed Pharmacother. 2017 Dec;96:198-207
pubmed: 28987943
BMC Musculoskelet Disord. 2011 Jun 30;12:144
pubmed: 21714933
Science. 2004 Nov 5;306(5698):997
pubmed: 15528436
Arthritis Rheum. 2011 Sep;63(9):2732-43
pubmed: 21590680
Curr Opin Rheumatol. 2015 May;27(3):289-94
pubmed: 25784380
Ann Rheum Dis. 2016 Apr;76(4):748-755
pubmed: 27789465
J Dent Res. 2012 Jul;91(7):651-8
pubmed: 22302144
PLoS One. 2017 Jun 30;12(6):e0179797
pubmed: 28665939
J Orthop Res. 2017 Feb;35(2):311-320
pubmed: 27082319
Cell. 2014 Dec 4;159(6):1365-76
pubmed: 25480299
Sci Rep. 2016 Jun 08;6:27611
pubmed: 27271770
PLoS Genet. 2012;8(11):e1003105
pubmed: 23209448
Osteoarthritis Cartilage. 2007 Jun;15(6):695-700
pubmed: 17207643
Nat Cell Biol. 2009 Sep;11(9):1157-63
pubmed: 19701194
Nat Rev Mol Cell Biol. 2013 Oct;14(10):643-53
pubmed: 23989958
Nat Protoc. 2008;3(8):1253-60
pubmed: 18714293
Arthritis Rheum. 2009 Jul;60(7):2037-45
pubmed: 19565477
Cell. 2014 Feb 13;156(4):730-43
pubmed: 24529376
Nat Rev Rheumatol. 2016 Jul;12(7):412-20
pubmed: 27192932
Genes Dev. 2008 Jan 1;22(1):50-65
pubmed: 18172165
Osteoarthritis Cartilage. 2007 Sep;15(9):1061-9
pubmed: 17470400
Ann Rheum Dis. 2016 Jul;75(7):1372-9
pubmed: 26253096
Clin Ter. 2010;161(1):25-8
pubmed: 20393674
Rheumatology (Oxford). 2011 May;50(5):838-51
pubmed: 21172926

Auteurs

Mohammad Y Ansari (MY)

Northeast Ohio Medical University, Rootstown.

Nazir M Khan (NM)

Northeast Ohio Medical University, Rootstown.

Nashrah Ahmad (N)

Northeast Ohio Medical University, Rootstown, and Kent State University, Kent, Ohio.

Jonathan Green (J)

Northeast Ohio Medical University, Rootstown.

Kimberly Novak (K)

Northeast Ohio Medical University, Rootstown.

Tariq M Haqqi (TM)

Northeast Ohio Medical University, Rootstown.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH